Practical Recommendations in Immuno and Molecular Oncology (PRIMO)
February 7-10 2024
Lihue, Kaua’i, HI
DISCLOSURE INDEXThe Medical Educator Consortium, Inc. in accordance with the Joint Accreditation Criteria and the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, has implemented a process where everyone who is in a position to control the content of a CME/CE activity has disclosed to us all relevant financial relationships with any ineligible company that they have had over the past 24 months. There is no minimum financial threshold; disclosure must be made regardless of whether the person views the financial relationships as relevant to the education. The ACCME defines an ineligible company as any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. MEC has implemented a mechanism to identify, mitigate and disclose relevant financial relationships prior to the education activity being delivered to learners.
As a Joint Accreditation (JA) Provider, decisions in the planning process of this conference were made free of the control of ineligible companies. All individuals who are in a position to control the content of this educational activity have disclosed all relevant financial relationships with any ineligible companies to the provider. This disclosure includes all persons in control of content to include staff and educational committee members involved in the planning process.
The ACCME defines an ineligible company as any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be ineligible companies.
Speakers/Moderators – Reported Relevant Financial Disclosure(s)
Jared D. Acoba, MD
Grant/Research Support: GSK
Other: Virtual Round Table: AstraZeneca
Sanjiv S. Agarwala, MD
Has no relevant financial relationships
Manmeet S. Ahluwalia, MD, MBA, FASCO
Grant/Research Support: AstraZeneca, AbbVie, BMS, Bayer, Incyte, Pharmacyclics, Novocure Inc., Merck, MimiVac, Seagen and Novartis
Consultant: Bayer, Novocure, Kiyatec, Insightec, GSK, Xoft, Nuvation, Cellularity, SDP Oncology, Apollomics, Prelude, Janssen, Tocagen, Voyager Therapeutics, Viewray, Caris Lifesciences, Pyramid Biosciences, Varian Medical Systems, Cairn Therapeutics, Anheart Therapeutics, Theraguix, Menarini Ricerche, Autem Therapeutics
Stock Shareholders: CytoDyn, Doctible, MimiVax, and MedInnovate Advisors LLC
Scientific Advisory Board: Cairn Therapeutics, Pyramid Biosciences, Modifi Biosciences., Bugworks
Daniel H. Ahn, DO, MS
Grant/Research Support: Bayer, AstraZeneca
Consultant: Incyte, Exelixis, Novartis
Stock Shareholders: Natera
Paul A. Bunn, MD
Consultant/DMC: BMS, Daiichi, Merck
Consultant: C Stone Pharmaceuticals, Ascentage, Imidex, AstraZeneca,Genentech, Verastem
Michael Carney, MD
Has no relevant financial relationships
Don S. Dizon, MD, FACP, FASCO
Grant/Research Support: Bristol Myers Squibb
Consultant: AstraZeneca, Glaxo SmithKline, Pfizer
Stock Shareholders: Midi, Doximity
Benjamin Falit, MD, JD
Has no relevant financial relationships
Jami Fukui, MD
Grant/Research Support: Hope Foundation (Ended)
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE
Grant/Research Support: Pharmacosmos
Barbara Goff, MD
Has no relevant financial relationships
William J. Gradishar MD, FASCO, FACP
Consultant: Roche/Genentech, AstraZeneca, SeaGen, Immunomedics, Novartis, Gilead, Lilly
Matthew Gubens, MD, MS
Grant/Research Support: Amgen, JNJ, Merck, OncoMed, Trizell
Consultant: AnHeart, AstraZeneca, Atreca, Cardinal Health, Genzyme, Genentech/Roche, Gilead, Guardant, Invitae, iTeos, Merus, Sanofi, Summit, Surface Oncology
Scott Huntington, MD, MPH
Grant/Research Support: Celgene, DTRM BioPharma, TG Therapeutics, Debiopharm Group, Agios
Consultant: SeaGen, Janssen, Bayer, BeiGene, Epizyme, Lilly, Servier, Genentech, Abbvie, Flatiron, Novartis, BeiGene, AstraZeneca, ADC Therapeutics, Merck, TG Therapeutics, TYME Technologies Inc., Arvinas, Pharmacyclics, AstraZeneca
Komal Jhaveri, MD, FACP
Grant/Research Support: Novartis, Genentech, Astra Zeneca, ADC Therapeutics, Novita Pharmaceuticals, Debio Pharmaceuticals, Pfizer, Lilly Pharmaceuticals, Zymeworks, Gilead, PUMA Biotechnology, Merck Pharmaceuticals, Scorpion Therapeutics, Blueprint Medicine
Consultant: Novartis, Pfizer, BMS, Jounce Therapeutics, Taiho Oncology, Genentech/Roche, AbbVie, Eisai, Astra Zeneca, Blueprint Medicine, Daiichi Sankyo, Seattle Genetics, Lilly/Loxo Oncology, Sun Pharma Advanced Research Company Ltd, Menarini/Stemline, Scorpion
Therapeutics
Catherine Lai, MD, MPH
Consultant: Jazz Pharma, PDS Biotechnology, Astellas (All Ended)
Speakers’ Bureau: OncLive, BioAscent (All Ended)
Other: Advisory: Bristol Myers Squibb, Genentech, AbbVie, Novartis, Pfizer
Glenn J. Lesser, MD, FACP
Grant/Research Support: Novocure Biopharma, LLC, Pharma America, ABM Therapeutics
Consultant: Servier Pharmaceuticals, ONO Pharma, Inc
Sagar Lonial, MD, FACP
Grant/Research Support: Takeda, Novartis, Janssen, BMS
Consultant: Amgen, Novartis, BMS, GSK, ABBVIE, Genentech, Pfizer, Janssen, Takeda, Regeneron
Other: Stock TG therapeutics
Ravi A. Madan, MD
Has no relevant financial relationships
Tricia Maeda, RN, BSN
Has no relevant financial relationships
Shane Y. Morita, MD, MS, PhD, FACS
Has no relevant financial relationships
Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS
Grant/Research Support: Corcept Therapeutics, AstraZeneca
Consultant: AstraZeneca, Merck, Daiichi Sankyo, GSK, Genentech
Luis E. Raez, MD, FACP, FCCP
Grant/Research Support: BMS, AstraZeneca, Lilly Oncology, Merck, Pfizer Nanthealth, Natera, Guardant Health, VELOS, TG Therapeutics, LOXO Pharmaceuticals, BioAlta, Merus, Seagen
Hope S. Rugo, MD, FASCO
Grant/Research Support: AstraZeneca; Daiichi Sankyo, Inc.; F. Hoffmann-La Roche AG/Genentech, Inc.; Gilead Sciences, Inc.; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer; Stemline Therapeutics, OBI Pharma; Ambryx
Consultant/Advisory: Daiichi Sankyo; Mylan/Viatris; NAPO; Eisai
Ritu Salani, MD, MBA
Consultant: Merck, GSK, Seagen, Regeneron, Eisai, Up To Date,
Edgardo S. Santos Castillero, MD, FACP
Consultant: AstraZeneca, Abbvie, Genentech, Sanofi, Regeneron, Novartis
Speakers’ Bureau: Amgen, AstraZeneca, Bristol-Myers Squib, Genentech, Lilly, EMD Serono, G1 Therapeutics, Jazz Pharmaceuticals, Merck, Mirati, Pfizer, Regeneron, Sanofi, Sobi Pharmaceutical Co., Takeda
Priyanka Sharma, MD
Grant/Research Support: Novartis, Bristol-Meyers Squibb, Merck, Gilead
Consultant/Advisory Board: Pfizer, Merck, Gilead, Seattle Genetics, Novartis, AstraZeneca, GSK
Rachna Shroff, MD, MS, FASCO
Grant/Research Support: Bayer, BMS, Bristol-Myers Squibb, Merck, Exelixis Pharmaceuticals, Haloyzme, Pieris, Taiho, Rafael Pharmaceuticals, IMV inc., LOXO, Novocure, NUCANA, QED Therapeutics, Seagen
Consultant/Advisory Boards: Merck, Exelixis, Seattle Genetics, QED, Debiopharm, Agios, Clovis, Astra Zeneca, Incyte, Zymeworks Biopharm., SYROS, Astellas, Natera, Hookipa Pharm., AbbVie, Duo Oncology, Ability Pharm., Servier
Guru P. Sonpavde, MD
Grant/Research Support: Sanofi, Astrazeneca, Gilead, Helsinn, Lucence, EMD Serono, Jazz Therapeutics
Consultant: EMD Serono, BMS, Merck, Seattle Genetics/Astellas, Janssen, Bicycle Therapeutics, Pfizer, Gilead, Scholar Rock, G1 Therapeutics, Eli Lilly/Loxo Oncology, Lucence Health, IMV, Vial, Tempus, Ellipses Pharma, PrecisCa, Suba Therapeutics, Syapse, Merck, Servier, Syncorp
Speakers’ Bureau: Seagen, Gilead, Natera, Exelixis, Janssen, Bayer, Aveo
Other: DSM: Mereo,
Ulka Vaishampayan, MD
Grant/Research Support: Merck Inc, Bristol Myers Squibb Inc
Consultant: Merck, Exelixis, Gilead, Sanofi, Alkermes, Bristol-Myers-Squibb, Bayer, Pfizer
Speakers’ Bureau: Bayer, Exelixis
Julie M. Vose, MD, MBA
Grant/Research Support: Abbvie, Janssen, AstraZeneca, MEI Pharma, Johnson & Johnson, Daiichi Sankyo, Pharmacyclics, Genentech, BMS, Lilly
Consultant: Abbvie, Janssen, Astra-Zeneca, MEI Pharma, Johnson & Johnson, Daiichi Sankyo, Pharmacyclics, Genentech, BMS, Lilly
Kevin Wilcox, MD
Has no relevant financial relationships
Planning Committee – Reported Relevant Financial Disclosure(s)
Sanjiv S. Agarwala, MD
Has no relevant financial relationships
Don S. Dizon, MD, FACP, FASCO
Grant/Research Support:
Bristol Myers Squibb
Consultant: AstraZeneca, Glaxo SmithKline, Pfizer
Stock Shareholders: Midi, Doximity
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE
Grant/Research Support: Pharmacosmos
Tricia Maeda, RN, BSN
Has no relevant financial relationships
Shane Y. Morita, MD, MS, PhD, FACS
Has no relevant financial relationships
Luis E. Raez, MD, FACP, FCCP
Grant/Research Support: BMS, AstraZeneca, Lilly Oncology, Merck, Pfizer Nanthealth, Natera, Guardant Health, VELOS, TG Therapeutics, LOXO Pharmaceuticals, BioAlta, Merus, Seagen
Hope S. Rugo, MD, FASCO
Grant/Research Support: AstraZeneca; Daiichi Sankyo, Inc.; F. Hoffmann-La Roche AG/Genentech, Inc.; Gilead Sciences, Inc.; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer; Stemline Therapeutics, OBI Pharma; Ambryx
Consultant/Advisory: Daiichi Sankyo; Mylan/Viatris; NAPO; Eisai
Edgardo S. Santos Castillero, MD, FACP
Consultant: AstraZeneca, Abbvie, Genentech, Sanofi, Regeneron, Novartis
Speakers’ Bureau: Amgen, AstraZeneca, Bristol-Myers Squib, Genentech, Lilly, EMD Serono, G1 Therapeutics, Jazz Pharmaceuticals, Merck, Mirati, Pfizer, Regeneron, Sanofi, Sobi Pharmaceutical Co., Takeda
Amy Schippers, PA-C
Has no relevant financial relationships
Rachna Shroff, MD, MS, FASCO
Grant/Research Support: Bayer, BMS, Bristol-Myers Squibb, Merck, Exelixis Pharmaceuticals, Haloyzme, Pieris, Taiho, Rafael Pharmaceuticals, IMV inc., LOXO, Novocure, NUCANA, QED Therapeutics, Seagen
Consultant/Advisory Boards: Merck, Exelixis, Seattle Genetics, QED, Debiopharm, Agios, Clovis, Astra Zeneca, Incyte, Zymeworks Biopharm., SYROS, Astellas, Natera, Hookipa Pharm., AbbVie, Duo Oncology, Ability Pharm., Servier
Teri Valls, CMP, CMM
Has no relevant financial relationships
Julie M. Vose, MD, MBA
Grant/Research Support: Abbvie, Janssen, AstraZeneca, MEI Pharma, Johnson & Johnson, Daiichi Sankyo, Pharmacyclics, Genentech, BMS, Lilly
Consultant: Abbvie, Janssen, Astra-Zeneca, MEI Pharma, Johnson & Johnson, Daiichi Sankyo, Pharmacyclics, Genentech, BMS, Lilly
CME Reviewers – Reported Relevant Financial Disclosure(s)
Sanjiv S. Agarwala, MD
Has no relevant financial relationships
Lynne Davidson
Has no relevant financial relationships
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE
Grant/Research Support: Pharmacosmos
Tricia Maeda, RN, BSN
Has no relevant financial relationships
Amy Schippers, PA-C
Has no relevant financial relationships
Teri Valls, CMP, CMM
Has no relevant financial relationships
All of the relevant financial relationships listed for these individuals have been mitigated.
SPEAKERS WILL DIRECTLY DISCLOSE THE USE OF PRODUCTS FOR WHICH ARE NOT LABELED (E.G., OFF LABEL USE) OR IF THE PRODUCT IS STILL INVESTIGATIONAL. EACH SPEAKER HAS BEEN REQUESTED TO KEEP THEIR PRESENTATION UNBIASED AND GENERIC WHEN APPLICABLE.